Wellcome Trust | Wellcome Trust Sanger Institute | Henry Wellcome | Wellcome Library | Wellcome Trust Genome Campus | Wellcome Trust Centre for Stem Cell Research | Wellcome |
The Court rejected a challenge by the generic drug manufacturers Novopharm and Apotex to declare Glaxo Wellcome's patent for AZT, an AIDS-fighting drug, invalid.
•
In February 1985, the NIH reported the positive results of their screening to Glaxo Wellcome, and, on March 16, 1985, Glaxo Wellcome filed a patent application for a new use of AZT in the United Kingdom.